Xpeer’s success is rooted in its innovative approach to delivering UEMS-accredited, bite-sized content, allowing HCPs to access training in short, impactful sessions. This model has transformed how HCPs interact with medical education, offering a template for pharma engagement with HCPs. Our journey, marked by adapting to global shifts like the COVID-19 pandemic, continues to prioritize the evolving needs of HCPs and provide actionable insights for pharma leaders.
Xpeer’s journey: innovating CME for HCPs
Built on over 20 years of experience in organizing medical congresses, Xpeer set out to make CME more accessible for healthcare professionals. Our platform—designed like Netflix for CME—delivers UEMS-accredited, bite-sized videos, allowing HCPs to learn between patient visits or during short breaks. This innovative approach has made our content highly engaging, with HCPs spending an average of 20 minutes per session.
Pharma companies can learn from this. In today’s fast-paced medical environment, engagement needs to be seamless, providing educational content that is accessible, relevant, and available on-demand. Bite-sized, high-impact formats fit into their busy schedules and are essential for maximizing interaction.
What we’ve learned: 5 key insights for pharma engagement
After five years of growth and feedback from thousands of HCPs, we have identified five actionable strategies that can help improve engagement:
- Digital first, but not digital only
While omnichannel engagement strategies are gaining traction, 67% of HCPs still prefer a mix of digital and face-to-face interactions. Pharma leaders should strike a balance between digital tools and human connections to ensure every touchpoint delivers value. - CME-accredited content builds trust
Xpeer’s platform is accredited by the European Union of Medical Specialists (UEMS), covering over 1.6 million medical professionals in 27 countries. Accreditation signals impartiality and scientific rigor, which HCPs value. Pharma companies should prioritize similar CME-accredited content to establish credibility and enhance engagement. - Bite-sized content drives engagement
Microlearning, such as short videos, infographics, and interactive sessions, fits into HCPs’ busy lives better than long-form content. Pharma should focus on creating modular educational formats that are easily consumable and actionable. - Data-driven strategies enhance impact
At Xpeer, we analyze user data—such as session durations and content preferences—to refine our offerings. This approach has resulted in engagement rates exceeding 80%. Companies can similarly leverage data analytics to optimize their strategies. - Unbranded, value-driven education fosters long-term relationships
HCPs prioritize educational content that enhances their clinical practice, with 72% favoring disease information over product promotions. Offering unbranded, valuable insights helps pharma build trust and maintain meaningful connections.
The future of pharma engagement with HCPs
As Xpeer celebrates its 5th anniversary, we remain committed to delivering impactful medical education. Looking ahead, we see several trends shaping the future of engagement:
- Personalized learning experiences: Tailoring content based on specialty, region, and past interactions will keep HCPs more engaged.
- AI-driven insights: Artificial intelligence will enable personalized content delivery and provide real-time analysis of engagement patterns.
- Omnichannel integration: Combining digital and in-person interactions across multiple platforms will create a seamless engagement experience.
At Xpeer, we’ve demonstrated that sustained, meaningful engagement with HCPs is possible. By offering trusted, valuable education and aligning with the evolving needs of healthcare professionals, pharma companies can foster deeper connections and improve healthcare outcomes.
Here’s to the next five years of growth, learning, and innovation!
By Daniela Clape
CEO & Founder of Xpeer
